Benzinga Rankings give you vital metrics on any stock – anytime.
Explore CARISMA Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CARM.
You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.
Other companies in CARISMA Therapeutics’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), HOOKIPA Pharma (NASDAQ:HOOK), Acurx Pharmaceuticals (NASDAQ:ACXP) and Evaxion Biotech (NASDAQ:EVAX).
CARISMA Therapeutics has a consensus price target of $7.34.
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $0.1878 last updated April 17, 2025 at 4:35 PM EDT.
There are no upcoming dividends for CARISMA Therapeutics.
CARISMA Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for CARISMA Therapeutics.
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.